EDWARDS, STIRLING, JOHN,PEARSE, MARTIN, JOHN,SCHEERLINCK, JEAN-PIERRE, YVES,SUTTON, PHIL
申请号：
NZ57514107
公开号：
NZ575141A
申请日:
2007.08.31
申请国别(地区):
NZ
年份:
2012
代理人:
摘要：
Disclosed is the use of a composition consisting essentially of a protein, polypeptide or peptide antigen, a saponin-based adjuvant, and optionally one or more adjuvants selected from the group consisting of liposomes, oil-in-water adjuvants, aluminium salt adjuvants, lipopolysaccharide adjuvants, oligonucleotide adjuvants and mucosal adjuvants, in the manufacture of a medicament wherein the medicament if formulated for intra-lung administration to a human or animal subject to elicit an immune response in the subject.
